Novo Nordisk | NVO - Market Capitalization


Novo Nordisk reported DKK138.17B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
ANI Pharmaceuticals USD 1.46B 206M Nov/2026
Aurora Cannabis CAD 318.09M 145.93M Nov/2026
Bausch Health Companies USD 4.13B 1.95B Nov/2026
Bristol-Myers Squibb USD 127.46B 9.81B Sep/2026
Canopy Growth CAD 88.38M 494.19M Nov/2026
Corcept Therapeutics USD 7.63B 4.83B Nov/2026
Drreddys Laboratories INR 2.29B 8.43B Nov/2026
Eli Lilly USD 1.09T 40.33B Sep/2026
GlaxoSmithKline GBP 74.11B 6.03B Sep/2026
Merck USD 375.59B 17.09B Nov/2026
Nektar Therapeutics USD 2.12B 1.26B Mar/2026
Novartis USD 292.09B 51.5B Sep/2026
Novo Nordisk DKK 212.17B 55.02B Jun/2026
Novo Nordisk A/S DKK 1.4T 373.76B Jun/2026
Pacira USD 1.7B 696M Nov/2026
Perrigo USD 2.17B 31M Nov/2026
Phibro Animal Health USD 1.51B 126M Dec/2025
Prestige Brands USD 2.2B 38M Nov/2026
Sanofi EUR 100.56B 13.53B Nov/2026
Supernus Pharmaceuticals USD 2.51B 193M Sep/2026
Zoetis USD 37.6B 8.74B Nov/2026